Tuesday, October 20, 2020
Home Innovation That Matters

Innovation That Matters

Big Ideas Yield Transformative Results for SMA Patients

As part of this year’s SMA Awareness month, we interviewed Stuart Peltz, the Founder and CEO of PTC Therapeutics. He shares his company’s R&D journey that led to the approval of Evrysdi™ (risdiplam), the first-ever oral treatment for spinal muscular atrophy. The...

One-Stop Cell and Gene Therapy Solutions for Global Innovators: A Conversation with David Chang, CEO of WuXi ATU

In the past few years, the field of cell and gene therapy has witnessed major breakthroughs. It has become one of the hottest fields in the biotech industry, with the hope that it will eventually revolutionize the way we treat diseases and,...

TG Therapeutics’ Early Oncology Research Leading to New MS Therapeutic

At TG Therapeutics in New York City the company didn’t start out looking for new therapies for Multiple Sclerosis (MS). TG began as an oncology focused company but as the data came in from their research the company and President and CEO...

Disease-Modifying RNA Therapies from Recode Therapeutics Target Rare Lung Diseases

The recent merger of TranscripTx and ReCode Therapeutics created a company that combines RNA drug expertise with a non-viral lipid nanoparticle (LNP) delivery platform to develop new genetic therapies for treating the underlying causes of two rare lung diseases: cystic fibrosis and...

Powerhouse Collaborator, MassBio’s President & CEO, Bob Coughlin Optimistically Embraces Industry Changes

MassBio is a 35-year standing life sciences trade association consisting of over 1,300 member companies. Today, their programs, services, and industry-critical mass influence, allows them to be truly patient-driven. By utilizing their unparalleled network of innovative companies and industry thought leaders, MassBio...




Twitter LinkedIn